280 related articles for article (PubMed ID: 23939888)
21. Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae.
Tascini C; Tagliaferri E; Giani T; Leonildi A; Flammini S; Casini B; Lewis R; Ferranti S; Rossolini GM; Menichetti F
Antimicrob Agents Chemother; 2013 Aug; 57(8):3990-3. PubMed ID: 23752510
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
[TBL] [Abstract][Full Text] [Related]
23. Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: Emergence of hypermucoviscous ST25 and high-risk clone ST307.
Cejas D; Elena A; Guevara Nuñez D; Sevillano Platero P; De Paulis A; Magariños F; Alfonso C; Berger MA; Fernández-Canigia L; Gutkind G; Radice M
J Glob Antimicrob Resist; 2019 Sep; 18():238-242. PubMed ID: 31202977
[TBL] [Abstract][Full Text] [Related]
24. Activity of Ceftazidime-Avibactam Against Clinical Isolates of Klebsiella pneumoniae, Including KPC-Carrying Isolates, Endemic to New York City.
Manning N; Balabanian G; Rose M; Landman D; Quale J
Microb Drug Resist; 2018; 24(1):35-39. PubMed ID: 28590820
[TBL] [Abstract][Full Text] [Related]
25. Genomic characterisation of a colistin-resistant Klebsiella pneumoniae ST11 strain co-producing KPC-2, FloR, CTX-M-55, SHV-12, FosA and RmtB causing a lethal infection.
Xiaoliang W; Huiming H; Chunlei C; Beiwen Z
J Glob Antimicrob Resist; 2019 Dec; 19():78-80. PubMed ID: 31493525
[TBL] [Abstract][Full Text] [Related]
26. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
Wise MG; Horvath E; Young K; Sahm DF; Kazmierczak KM
J Med Microbiol; 2018 Mar; 67(3):289-295. PubMed ID: 29458684
[TBL] [Abstract][Full Text] [Related]
27. Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary.
Tóth A; Damjanova I; Puskás E; Jánvári L; Farkas M; Dobák A; Böröcz K; Pászti J
Eur J Clin Microbiol Infect Dis; 2010 Jul; 29(7):765-9. PubMed ID: 20401676
[TBL] [Abstract][Full Text] [Related]
28. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin.
Cannatelli A; Giani T; D'Andrea MM; Di Pilato V; Arena F; Conte V; Tryfinopoulou K; Vatopoulos A; Rossolini GM;
Antimicrob Agents Chemother; 2014 Oct; 58(10):5696-703. PubMed ID: 25022583
[TBL] [Abstract][Full Text] [Related]
29. Genomic analysis of a pan-resistant Klebsiella pneumoniae sequence type 11 identified in Japan in 2016.
Nishida S; Ono Y
Int J Antimicrob Agents; 2020 Apr; 55(4):105854. PubMed ID: 31770626
[TBL] [Abstract][Full Text] [Related]
30. The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.
Sho T; Muratani T; Hamasuna R; Yakushiji H; Fujimoto N; Matsumoto T
Microb Drug Resist; 2013 Aug; 19(4):274-81. PubMed ID: 23514607
[TBL] [Abstract][Full Text] [Related]
31. Ceftazidime-Avibactam Resistance Associated with Increased
Coppi M; Di Pilato V; Monaco F; Giani T; Conaldi PG; Rossolini GM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964792
[TBL] [Abstract][Full Text] [Related]
32. Effects of KPC Variant and Porin Genotype on the
Wilson WR; Kline EG; Jones CE; Morder KT; Mettus RT; Doi Y; Nguyen MH; Clancy CJ; Shields RK
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617090
[TBL] [Abstract][Full Text] [Related]
33. Colistin Resistance in KPC-2- and SHV-5-Producing Klebsiella pneumoniae Clinical Isolates in Bulgaria.
Savov E; Todorova I; Politi L; Trifonova A; Borisova M; Kioseva E; Tsakris A
Chemotherapy; 2017; 62(6):339-342. PubMed ID: 28738348
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
Gaibani P; Lombardo D; Lewis RE; Mercuri M; Bonora S; Landini MP; Ambretti S
J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503
[TBL] [Abstract][Full Text] [Related]
35. Spread of Carbapenem and Colistin-Resistant Klebsiella pneumoniae ST512 Clinical Isolates in Israel: A Cause for Vigilance.
Lalaoui R; Bakour S; Livnat K; Assous MV; Diene SM; Rolain JM
Microb Drug Resist; 2019; 25(1):63-71. PubMed ID: 30129868
[TBL] [Abstract][Full Text] [Related]
36. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014.
Monaco M; Giani T; Raffone M; Arena F; Garcia-Fernandez A; Pollini S; ; Grundmann H; Pantosti A; Rossolini GM
Euro Surveill; 2014 Oct; 19(42):. PubMed ID: 25358041
[TBL] [Abstract][Full Text] [Related]
37. Klebsiella pneumoniae ST258 producing KPC-3 identified in italy carries novel plasmids and OmpK36/OmpK35 porin variants.
García-Fernández A; Villa L; Carta C; Venditti C; Giordano A; Venditti M; Mancini C; Carattoli A
Antimicrob Agents Chemother; 2012 Apr; 56(4):2143-5. PubMed ID: 22252815
[TBL] [Abstract][Full Text] [Related]
38. Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam.
Galani I; Antoniadou A; Karaiskos I; Kontopoulou K; Giamarellou H; Souli M
Clin Microbiol Infect; 2019 Jun; 25(6):763.e5-763.e8. PubMed ID: 30928562
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
[TBL] [Abstract][Full Text] [Related]
40. In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment.
Cannatelli A; Di Pilato V; Giani T; Arena F; Ambretti S; Gaibani P; D'Andrea MM; Rossolini GM
Antimicrob Agents Chemother; 2014 Aug; 58(8):4399-403. PubMed ID: 24841267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
